A detailed history of Keebeck Wealth Management, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Keebeck Wealth Management, LLC holds 13,748 shares of PFE stock, worth $360,335. This represents 0.06% of its overall portfolio holdings.

Number of Shares
13,748
Previous 13,638 0.81%
Holding current value
$360,335
Previous $381,000 4.2%
% of portfolio
0.06%
Previous 0.06%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$27.7 - $31.39 $3,047 - $3,452
110 Added 0.81%
13,748 $397,000
Q2 2024

Aug 14, 2024

BUY
$25.26 - $29.6 $8,158 - $9,560
323 Added 2.43%
13,638 $381,000
Q1 2024

May 14, 2024

BUY
$25.89 - $29.73 $344,725 - $395,854
13,315 New
13,315 $369,000
Q3 2023

Nov 14, 2023

SELL
$32.09 - $37.51 $2,085 - $2,438
-65 Reduced 1.05%
6,119 $202,000
Q4 2022

Feb 14, 2023

SELL
$41.75 - $54.5 $1,252 - $1,635
-30 Reduced 0.48%
6,184 $316,000
Q3 2022

Nov 14, 2022

SELL
$43.76 - $53.42 $41,134 - $50,214
-940 Reduced 13.14%
6,214 $272,000
Q2 2022

Aug 15, 2022

BUY
$46.53 - $55.17 $54,998 - $65,210
1,182 Added 19.79%
7,154 $375,000
Q4 2021

Feb 14, 2022

BUY
$41.32 - $61.25 $22,478 - $33,320
544 Added 10.02%
5,972 $353,000
Q3 2021

Nov 16, 2021

SELL
$39.25 - $50.42 $151,308 - $194,369
-3,855 Reduced 41.53%
5,428 $233,000
Q4 2020

Feb 16, 2021

BUY
$33.47 - $42.56 $99,238 - $126,190
2,965 Added 46.93%
9,283 $342,000
Q3 2020

Nov 02, 2020

BUY
$31.75 - $37.25 $28,257 - $33,152
890 Added 16.4%
6,318 $231,000
Q2 2020

Aug 06, 2020

BUY
$30.12 - $36.54 $163,491 - $198,339
5,428 New
5,428 $177,000
Q1 2020

May 14, 2020

SELL
$27.03 - $38.62 $165,450 - $236,393
-6,121 Closed
0 $0
Q4 2019

Feb 14, 2020

BUY
$32.92 - $37.36 $201,503 - $228,680
6,121 New
6,121 $239,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $147B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Keebeck Wealth Management, LLC Portfolio

Follow Keebeck Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Keebeck Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Keebeck Wealth Management, LLC with notifications on news.